TerminatedNCT06618118

B Experimental Medicine Study of Fosigotifator in Adults With Major Depressive Disorder

Medication studyAges 20–70United StatesDepression

The study in practice

Understand this study

This study is for people with depression. Listed age limits: 20 years to 70 years. Other eligibility criteria apply.

Listed locations: Sherman Oaks and 3 more locationsSee all locations and recruitment
Study phase: Phase 1

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: October 23, 2024

Recruitment status: Terminated
Enrollment listed in the registry: 20
Sponsor: AbbVie
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 1
Locations: United States
Age range: From 20 Years to 70 Years
Official registry ID: NCT06618118
Official title: Show the full official title
A Phase 1 b Randomized, Double-blind, Placebo-Controlled, Experimental Medicine Study of Fosigotifator in Adults With Major Depressive Disorder

Terminated

Sherman Oaks · Orlando · Decatur

1 more locations

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is AbbVie.

Does this study involve medication?

Yes. The study involves medication, including Fosigotifator and Placebo.

Who can participate?

This study is for people with depression. Listed age limits: 20 years to 70 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.